BenchSci is a software company on a mission to empower scientists to accelerate drug discovery by running more successful experiments. Founded in 2015, BenchSci now employs 70+ professionals from headquarters in Toronto, Ontario, Canada. As an employer, the company has posted flexible opportunities, including remote, work-from-home jobs, in computer & IT, software development, account management, sales, science, and other fields for applicants with relevant experience and education.

BenchSci fosters a culture driven by its core values, which are described as FASTT: focused advancement with speed, tenacity, and transparency. For candidates who share these values, the company offers the opportunity to use cutting-edge technology to help scientists in academic labs and pharmaceutical companies deliver new treatments to patients with "horrible diseases like cancer, Zika, and Alzheimer's." Associates at BenchSci also enjoy working with people who are passionate about making an impact. This team is comprised of experts in science, engineering, commercialization, and technology. In addition to work-life balance, leadership offers a range of benefits that may include weekly catered dinners, access to an on-site gym, professional growth, and more.

Specifically, BenchSci works to solve the problem of failing reagents, which are critical ingredients in scientific experiments. According to the team, experiments fail when reagents fail, creating delays in making discoveries and developing new treatments. To solve this problem, the company offers a reagent intelligence platform that uses machine learning and artificial intelligence (AI) to transform published data into experiment-specific recommendations that reduce time, money, and risk in planning materials and methods. Today, BenchSci is self-described as the industry standard in AI-assisted antibody selection. Trusted by over 30,000 scientists worldwide, the company partners with leading scientific publishers like Wiley, Wolters Kluwer, PNAS, and more.

BenchSci is a software company on a mission to empower scientists to accelerate drug discovery by running more successful experiments. Founded in 2015, BenchSci now employs 70+ professionals from headquarters in Toronto, Ontario, Canada. As an employer, the company has posted flexible opportunities, including remote, work-from-home jobs, in computer & IT, software development, account management, sales, science, and other fields for applicants with relevant experience and education.

BenchSci fosters a culture driven by its core values, which are described as FASTT: focused advancement with speed, tenacity, and transparency. For candidates who share these values, the company offers the opportunity to use cutting-edge technology to help scientists in academic labs and pharmaceutical companies deliver new treatments to patients with "horrible diseases like cancer, Zika, and Alzheimer's." Associates at BenchSci also enjoy working with people who are passionate about making an impact. This team is comprised of experts in science, engineering, commercialization, and technology. In addition to work-life balance, leadership offers a range of benefits that may include weekly catered dinners, access to an on-site gym, professional growth, and more.

Specifically, BenchSci works to solve the problem of failing reagents, which are critical ingredients in scientific experiments. According to the team, experiments fail when reagents fail, creating delays in making discoveries and developing new treatments. To solve this problem, the company offers a reagent intelligence platform that uses machine learning and artificial intelligence (AI) to transform published data into experiment-specific recommendations that reduce time, money, and risk in planning materials and methods. Today, BenchSci is self-described as the industry standard in AI-assisted antibody selection. Trusted by over 30,000 scientists worldwide, the company partners with leading scientific publishers like Wiley, Wolters Kluwer, PNAS, and more.